ZA765752B - Ophthalmic composition containing t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-propanol hydrogen maleate - Google Patents

Ophthalmic composition containing t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-propanol hydrogen maleate

Info

Publication number
ZA765752B
ZA765752B ZA00765752A ZA765752A ZA765752B ZA 765752 B ZA765752 B ZA 765752B ZA 00765752 A ZA00765752 A ZA 00765752A ZA 765752 A ZA765752 A ZA 765752A ZA 765752 B ZA765752 B ZA 765752B
Authority
ZA
South Africa
Prior art keywords
thiadiazol
butylamino
yloxy
morpholino
composition containing
Prior art date
Application number
ZA00765752A
Other languages
English (en)
Inventor
C Stone
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA765752B publication Critical patent/ZA765752B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA00765752A 1975-09-26 1976-09-24 Ophthalmic composition containing t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-propanol hydrogen maleate ZA765752B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61711875A 1975-09-26 1975-09-26

Publications (1)

Publication Number Publication Date
ZA765752B true ZA765752B (en) 1978-05-30

Family

ID=24472326

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00765752A ZA765752B (en) 1975-09-26 1976-09-24 Ophthalmic composition containing t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-propanol hydrogen maleate

Country Status (12)

Country Link
AU (1) AU513280B2 (fr)
BE (1) BE846574A (fr)
CY (1) CY1023A (fr)
GB (1) GB1524405A (fr)
HK (1) HK67579A (fr)
IE (1) IE44167B1 (fr)
IL (1) IL50477A (fr)
KE (1) KE2990A (fr)
MY (1) MY8000138A (fr)
NZ (1) NZ182022A (fr)
PH (1) PH13467A (fr)
ZA (1) ZA765752B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
US4402976A (en) 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations

Also Published As

Publication number Publication date
AU513280B2 (en) 1980-11-27
GB1524405A (en) 1978-09-13
HK67579A (en) 1979-09-28
IE44167L (en) 1977-03-26
NZ182022A (en) 1978-12-18
MY8000138A (en) 1980-12-31
CY1023A (en) 1980-08-01
IL50477A0 (en) 1976-11-30
PH13467A (en) 1980-05-15
KE2990A (en) 1979-09-28
IE44167B1 (en) 1981-08-26
AU1771476A (en) 1978-03-23
IL50477A (en) 1979-09-30
BE846574A (fr) 1977-03-24

Similar Documents

Publication Publication Date Title
IL49229A0 (en) Novel polyamines,their preparation and their use as stabilizers for polyolefine compositions
SG3185G (en) Compositions containing 1,3-dimethyl-5-aminoadamantane
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
NZ182692A (en) Fungicidal composition mixtures containing 1-substituted-1,2,4-triazdes
GB2011917B (en) Rubber compositions containing 1,2-polybutadience
ZA763758B (en) Resin composition containing o,o,o',o'-tetramethyl o,o',-thiodi-p-phenylene phosphorothioate
PH15791A (en) Pharmaceutical composition containing 3,4-dihydro-3-oxoquinoxalines
DE3069095D1 (en) Electrode composition
PH12102A (en) 2,1,3-benzothiadiazole as myotonolytics
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
NZ183651A (en) Tribalo-n-alkyl-2',4',6'-trinitrodiphenylamines
IL50170A0 (en) Herbicidal compositions containing certain pyridazone-(6)derivatives,their production and their use
ZA767119B (en) Antifungal composition
ZA765752B (en) Ophthalmic composition containing t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-propanol hydrogen maleate
GB1532697A (en) 2,3-dihydroergolines
GB1557694A (en) 2,9 dichlorquinacridone
PH14168A (en) 2,4-pyrrolidinediones
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
EG12183A (en) 2-chloro-n-isoproyl-2',3'-imethylacetanilide
GB1554925A (en) 2,3-methyl-eneprostaglandins
AU1146076A (en) 4h-benzo%4,5<-cyclohepta%1,2-6<thiophene derivatives
IL49340A (en) Fungicidal compositions containing 1-aryl-5-alkylidene-2,4-dioxo-imidazolidines
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
AU1346176A (en) 1,2,3,4-tetrahydro-4-oxo-%or-oxy-<-1-naphthylureas
JPS5630401A (en) Polymer composition containing hydrogenated polybutadiene